Company profile for Elsie Biotechnologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Elsie Biotechnologies is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics by integrating discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery. Elsie’s discovery platform accesses the entire oligonucleotide chemistry space to optimize current modalities in gene silencing and splice switching and applies proprietary P(V) ...
Elsie Biotechnologies is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics by integrating discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery. Elsie’s discovery platform accesses the entire oligonucleotide chemistry space to optimize current modalities in gene silencing and splice switching and applies proprietary P(V) chemistry technologies to develop novel, diverse oligonucleotide therapeutics that are designed to be more potent, safer, and easier to deliver to target tissues.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10355 Science Center Drive, Suite 110 San Diego, CA 92121
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
GSK acquires oligonucleotide drug startup Elsie
GSK acquires oligonucleotide drug startup Elsie

07 Jun 2024

// Delilah Alvarado BIOPHARMADIVE

https://www.biopharmadive.com/news/gsk-acquire-elsie-oligonucleotides-rna-drug/718257/

Delilah Alvarado BIOPHARMADIVE
07 Jun 2024
GSK dives even deeper into oligo strategy with Elsie pair-up
GSK dives even deeper into oligo strategy with Elsie pair-up

10 Jul 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/gsk-dives-even-deeper-oligo-strategy-elsie-biotechnology-pair

James Waldron FIERCE BIOTECH
10 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty